Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
Operating Expenses | 10,425 | 6,325 | 2,848 | 1,744 | 504 |
Operating Income | -10,425 | -6,325 | -2,848 | -1,744 | -504 |
Interest Expense | 0 | 0 | 106 | 113 | 156 |
Other Income | 48 | 82 | 6 | -549 | -1 |
Pre-tax Income | -10,377 | -6,243 | -2,948 | -2,406 | -661 |
Net Income Continuous | -10,377 | -6,243 | -2,948 | -2,406 | -661 |
Net Income | $-10,377 | $-6,243 | $-2,948 | $-2,406 | $-661 |
EPS Basic Total Ops | -1,161.07 | -710.17 | -338.18 | -789.08 | -248.00 |
EPS Basic Continuous Ops | -1,158.29 | -719.01 | -333.21 | -783.87 | -246.48 |
EPS Diluted Total Ops | -1,161.07 | -710.17 | -338.18 | -789.08 | -248.00 |
EPS Diluted Continuous Ops | -1,158.29 | -719.01 | -333.21 | -783.87 | -246.48 |
EBITDA(a) | $-10,425 | $-6,325 | $-2,742 | $-1,709 | $-471 |